STERIS plc (STE)
Form 4 sales, Form 144 notices and lockup dates
- Latest sale
- $957k
- Aug 12 · No plan
- Form 4 sales
- 97
- On record
- Form 144 notices
- 6
- Proposed sales
- Next unlock
- None
- No lockup ahead
Lockups
No lockup on record.
Sales by reason
Timeline
- 1 Form 4 saleUnusualNov 11 2025
Sold 15,000 shares at $265.14 ($4M)
Zangerle John Adam, Sr. VP, Gen Counsel, and Sec.
No 10b5-1 planSold 30.8% of holdings ($12.9M position)33,669 shares leftFiling
- 2 Form 4 saleUnusualNov 18 +7 days
Sold 5,036 shares at $257.55 ($1.3M)
Tamaro Renato, V.P. & Corporate Treasurer
No 10b5-1 planSold 46.9% of holdings ($2.8M position)5,695 shares leftFiling
- 3 Form 4 saleUnusualNov 21 +3 days
Sold 5,008 shares at $262.00 ($1.3M)
Madsen Julia, Sr. VP and GM, Life Sciences
No 10b5-1 planSold 31.9% of holdings ($4.1M position)10,710 shares leftFiling
- 4 Form 4 saleUnusualMar 5 +104 days
Sold 3,098 shares at $237.21 ($735k)
Feldmann Cynthia L, Director
No 10b5-1 planSold 81.5% of holdings ($902k position)705 shares leftFiling
- 5 Form 4 saleNo planJun 2 +89 days
Sold 1,481 shares at $209.51 ($310k)
Breeden Richard C, Director
No 10b5-1 planSold 3.7% of holdings ($8.5M position)38,964 shares leftFirst sale on recordFiling
- 6 Form 4 saleRoutineJun 5 +3 days
Sold 4,428 shares at $213.82 ($947k)
Carestio Daniel A, President and CEO
10b5-1 planSold 6.5% of holdings ($14.6M position)63,647 shares leftFiling
- 7 Form 4 saleRoutineJun 15 +10 days
Sold 1,419 shares at $209.28 ($297k)
Zangerle John Adam, Sr. VP, Gen Counsel, and Sec.
10b5-1 planSold 3.9% of holdings ($7.7M position)35,259 shares leftFiling
- 8 Form 4 saleNo planAug 12 +58 days
Sold 4,058 shares at $235.78 ($957k)
Sohi Mohsen, Director
No 10b5-1 planSold 14.3% of holdings ($6.7M position)24,305 shares leftFiling
Every transaction
Loading transactions…
Sales, notices and lockups (103)
Export watchlist as CSV| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Aug 12, 2026 | Sohi Mohsen | Director | Form 4 sale | 4,058 | $957k | 14.3% | No plan | SEC |
| Jun 15, 2026 | Zangerle John Adam | Sr. VP, Gen Counsel, and Sec. | Form 4 sale | 1,419 | $297k | 3.9% | Routine | SEC |
| Jun 5, 2026 | Carestio Daniel A | President and CEO | Form 4 sale | 4,428 | $947k | 6.5% | Routine | SEC |
| Jun 2, 2026 | Breeden Richard C | Director | Form 4 sale | 1,481 | $310k | 3.7% | No plan | SEC |
| Mar 5, 2026 | Feldmann Cynthia L | Director | Form 4 sale | 3,098 | $735k | 81.5% | Unusual | SEC |
| Nov 21, 2025 | Madsen Julia | Sr. VP and GM, Life Sciences | Form 4 sale | 5,008 | $1.3M | 31.9% | Unusual | SEC |
| Nov 18, 2025 | Tamaro Renato | V.P. & Corporate Treasurer | Form 4 sale | 5,036 | $1.3M | 46.9% | Unusual | SEC |
| Nov 11, 2025 | Zangerle John Adam | Sr. VP, Gen Counsel, and Sec. | Form 4 sale | 15,000 | $4M | 30.8% | Unusual | SEC |
| Oct 6, 2025 | Carestio Daniel A | President and CEO | Form 4 sale | 159 | $38k | 0.3% | Routine | SEC |
| Aug 20, 2025 | Tamaro Renato | V.P. & Corporate Treasurer | Form 4 sale | 3,204 | $799k | 30.7% | Unusual | SEC |
| Aug 11, 2025 | Sohi Mohsen | Director | Form 4 sale | 4,110 | $994k | 15.5% | No plan | SEC |
| Aug 11, 2025 | Feldmann Cynthia L | Director | Form 4 sale | 3,495 | $844k | 83.2% | Unusual | SEC |
| Aug 11, 2025 | Burton Karen L | VP & CAO | Form 4 sale | 7,900 | $1.9M | 56.9% | Unusual | SEC |
| Jun 13, 2025 | Zangerle John Adam | Sr. VP, Gen Counsel, and Sec. | Form 4 sale | 1,978 | $478k | 5.5% | Routine | SEC |
| Jun 5, 2025 | Carestio Daniel A | President and CEO | Form 4 sale | 17,626 | $4.3M | 25.5% | Routine | SEC |
| May 20, 2025 | Majors Cary L | SVP and President, Healthcare | Form 4 sale | 12,828 | $3.2M | 53.0% | Unusual | SEC |
| Nov 25, 2024 | Majors Cary L | SVP and President, Healthcare | Form 4 sale | 1,682 | $366k | 12.9% | No plan | SEC |
| Nov 25, 2024 | Majors Cary L | Officer | Form 144 notice | 1,682 | $366k | Notice | SEC | |
| Sep 16, 2024 | Tokich Michael J | Sr. Vice Pres., CFO | Form 4 sale | 23,332 | $5.7M | 35.2% | Routine | SEC |
| Sep 10, 2024 | Tokich Michael J | Sr. Vice Pres., CFO | Form 4 sale | 23,332 | $5.8M | 35.2% | Routine | SEC |
| Aug 8, 2024 | Holland Christopher S | Director | Form 4 sale | 473 | $113k | 44.8% | Unusual | SEC |
| Jun 5, 2024 | Majors Cary L | SVP and President, Healthcare | Form 4 sale | 4,932 | $1.1M | 27.4% | Unusual | SEC |
| Jun 5, 2024 | Madsen Julia | Senior VP, Life Sciences | Form 4 sale | 3,652 | $840k | 27.4% | Unusual | SEC |
| May 16, 2024 | Tamaro Renato | V.P. & Corporate Treasurer | Form 4 sale | 1,154 | $267k | 14.7% | No plan | SEC |
| May 15, 2024 | Feldmann Cynthia L | Director | Form 4 sale | 2,000 | $475k | 73.9% | Unusual | SEC |
| May 15, 2024 | Tokich Michael J | Sr. Vice Pres., CFO | Form 4 sale | 32,000 | $7.5M | 43.0% | Unusual | SEC |
| May 14, 2024 | Sohi Mohsen | Director | Form 4 sale | 2,037 | $476k | 8.3% | No plan | SEC |
| May 14, 2024 | Burton Karen L | VP & CAO | Form 4 sale | 3,000 | $708k | 44.4% | Unusual | SEC |
| May 13, 2024 | Kosecoff Jacqueline B | Director | Form 4 sale | 4,584 | $1.1M | 100.0% | Unusual | SEC |
| May 13, 2024 | Majors Cary L | SVP and President, Healthcare | Form 4 sale | 2,024 | $470k | 15.1% | No plan | SEC |
| May 16, 2023 | Breeden Richard C | Director | Form 4 sale | 12,130 | $2.5M | 30.2% | Unusual | SEC |
| May 16, 2023 | Feldmann Cynthia L | Director | Form 4 sale | 2,058 | $430k | 74.5% | Unusual | SEC |
| May 16, 2023 | Feldmann Cynthia L | Director | Form 144 notice | 2,058 | $430k | Notice | SEC | |
| May 16, 2023 | Breeden Richard C | Director | Form 144 notice | 1,786 | $373k | Notice | SEC | |
| May 15, 2023 | Sohi Mohsen | Director | Form 4 sale | 2,069 | $439k | 8.5% | No plan | SEC |
| May 15, 2023 | Kosecoff Jacqueline B | Director | Form 4 sale | 4,657 | $990k | 100.0% | Unusual | SEC |
| May 15, 2023 | Breeden Richard C | Director | Form 4 sale | 2,737 | $578k | 6.4% | No plan | SEC |
| May 15, 2023 | Kosecoff Jacqueline B | Director | Form 144 notice | 4,657 | $990k | Notice | SEC | |
| May 15, 2023 | Breeden Richard C | Director | Form 144 notice | 13,081 | $2.8M | Notice | SEC | |
| May 15, 2023 | Sohi Mohsen | Director | Form 144 notice | 2,069 | $439k | Notice | SEC | |
| Mar 3, 2023 | Majors Cary L | SVP and President, Healthcare | Form 4 sale | 1,150 | $219k | 9.2% | Plan not stated | SEC |
| Dec 1, 2022 | Majors Cary L | SVP and President, Healthcare | Form 4 sale | 1,600 | $308k | 11.4% | Plan not stated | SEC |
| Jun 15, 2022 | Zangerle John Adam | Sr. VP, Gen Counsel, and Sec. | Form 4 sale | 2,659 | $546k | 8.7% | Plan not stated | SEC |
| Apr 20, 2022 | Zangerle John Adam | Sr. VP, Gen Counsel, and Sec. | Form 4 sale | 8,000 | $2M | 20.5% | Plan not stated | SEC |
| Apr 7, 2022 | Tokich Michael J | Sr. Vice Pres., CFO | Form 4 sale | 8,000 | $2M | 17.2% | Plan not stated | SEC |
| Mar 29, 2022 | Burton Karen L | VP, Controller & CAO | Form 4 sale | 4,000 | $984k | 38.6% | Unusual | SEC |
| Feb 15, 2022 | Burton Karen L | VP, Controller & CAO | Form 4 sale | 2,600 | $605k | 29.0% | Unusual | SEC |
| Feb 10, 2022 | Kosecoff Jacqueline B | Director | Form 4 sale | 3,218 | $757k | 100.0% | Unusual | SEC |
| Feb 10, 2022 | Feldmann Cynthia L | Director | Form 4 sale | 1,891 | $443k | 72.8% | Unusual | SEC |
| Dec 23, 2021 | Tokich Michael J | Sr. Vice Pres., CFO | Form 4 sale | 30,000 | $7.2M | 39.2% | Unusual | SEC |
| Nov 15, 2021 | Majors Cary L | Sr VP N America Com Operations | Form 4 sale | 1,950 | $454k | 13.3% | Plan not stated | SEC |
| Oct 22, 2021 | Tokich Michael J | Sr. Vice Pres., CFO | Form 4 sale | 20,000 | $4.7M | 30.1% | Unusual | SEC |
| Aug 26, 2021 | Tamaro Renato | V.P. & Corporate Treasurer | Form 4 sale | 1,449 | $310k | 21.2% | Plan not stated | SEC |
| Aug 13, 2021 | Majors Cary L | Sr VP N America Com Operations | Form 4 sale | 11,000 | $2.4M | 44.1% | Unusual | SEC |
| May 25, 2021 | Feldmann Cynthia L | Director | Form 4 sale | 4,000 | $763k | 85.0% | Unusual | SEC |
| May 21, 2021 | Kosecoff Jacqueline B | Director | Form 4 sale | 3,121 | $601k | 100.0% | Unusual | SEC |
| Apr 23, 2021 | Madsen Julia | Senior VP, Life Sciences | Form 4 sale | 1,000 | $215k | 17.7% | Plan not stated | SEC |
| Apr 20, 2021 | Madsen Julia | Senior VP, Life Sciences | Form 4 sale | 1,000 | $210k | 17.7% | Plan not stated | SEC |
| Jan 8, 2021 | Madsen Julia | Senior VP, Life Sciences | Form 4 sale | 1,000 | $202k | 17.7% | Plan not stated | SEC |
| Dec 1, 2020 | Lewis David B | Director | Form 4 sale | 1,560 | $302k | 18.9% | Plan not stated | SEC |
| Nov 9, 2020 | Rosebrough Walter M Jr | President & CEO | Form 4 sale | 10,000 | $1.9M | 16.3% | Plan not stated | SEC |
| Nov 9, 2020 | Madsen Julia | Senior VP, Life Sciences | Form 4 sale | 1,900 | $366k | 29.0% | Unusual | SEC |
| Nov 6, 2020 | Rosebrough Walter M Jr | President & CEO | Form 4 sale | 10,000 | $1.8M | 14.0% | Plan not stated | SEC |
| Nov 5, 2020 | Majors Cary L | Sr VP N America Com Operations | Form 4 sale | 2,000 | $360k | 11.7% | Plan not stated | SEC |
| Nov 5, 2020 | Burton Karen L | VP, Controller & CAO | Form 4 sale | 4,602 | $826k | 42.8% | Unusual | SEC |
| Oct 9, 2020 | Tokich Michael J | Sr. Vice Pres., CFO | Form 4 sale | 28,000 | $5.3M | 38.1% | Unusual | SEC |
| Oct 6, 2020 | Carestio Daniel A | Sr VP and Chief Operating Off | Form 4 sale | 13,500 | $2.5M | 33.9% | Unusual | SEC |
| Oct 1, 2020 | Zangerle John Adam | Sr. VP, Gen Counsel, and Sec. | Form 4 sale | 12,252 | $2.2M | 29.8% | Unusual | SEC |
| Sep 18, 2020 | Carestio Daniel A | Sr VP and Chief Operating Off | Form 4 sale | 15,000 | $2.6M | 36.3% | Unusual | SEC |
| Sep 15, 2020 | Carestio Daniel A | Sr VP and Chief Operating Off | Form 4 sale | 8,000 | $1.4M | 23.3% | Plan not stated | SEC |
| Sep 14, 2020 | Zangerle John Adam | Sr. VP, Gen Counsel, and Sec. | Form 4 sale | 2,000 | $334k | 6.5% | Plan not stated | SEC |
| Aug 25, 2020 | Breeden Richard C | Director | Form 4 sale | 45,000 | $6.9M | 62.3% | Unusual | SEC |
| Aug 10, 2020 | Majors Cary L | Sr VP N America Com Operations | Form 4 sale | 5,573 | $871k | 24.6% | Plan not stated | SEC |
| Aug 7, 2020 | Rosebrough Walter M Jr | President & CEO | Form 4 sale | 122,085 | $18.9M | 61.5% | Unusual | SEC |
| May 29, 2020 | Sohi Mohsen | Director | Form 4 sale | 3,218 | $528k | 12.6% | Plan not stated | SEC |
| Feb 19, 2020 | Rosebrough Walter M Jr | President & CEO | Form 4 sale | 72,255 | $12.1M | 49.9% | Unusual | SEC |
| Feb 13, 2020 | Sohi Mohsen | Director | Form 4 sale | 3,121 | $517k | 12.2% | Plan not stated | SEC |
| Feb 13, 2020 | Feldmann Cynthia L | Director | Form 4 sale | 2,000 | $333k | 85.5% | Unusual | SEC |
| Feb 12, 2020 | Lewis David B | Director | Form 4 sale | 3,133 | $522k | 31.9% | Unusual | SEC |
| Feb 12, 2020 | Kosecoff Jacqueline B | Director | Form 4 sale | 3,133 | $525k | 76.6% | Unusual | SEC |
| Feb 11, 2020 | Zangerle John Adam | Sr. VP, Gen Counsel, and Sec. | Form 4 sale | 3,000 | $486k | 9.5% | Plan not stated | SEC |
| Feb 11, 2020 | Burton Karen L | VP, Controller & CAO | Form 4 sale | 7,440 | $1.2M | 49.8% | Unusual | SEC |
| Dec 6, 2019 | Steeves Richard Martin | Director | Form 4 sale | 10,145 | $1.6M | 100.0% | Unusual | SEC |
| Dec 4, 2019 | Steeves Richard Martin | Director | Form 4 sale | 17,774 | $2.7M | 63.7% | Unusual | SEC |
| Oct 4, 2019 | Zangerle John Adam | Sr. VP, Gen Counsel, and Sec. | Form 4 sale | 1,000 | $142k | 3.4% | Plan not stated | SEC |
| Aug 14, 2019 | Tamaro Renato | V.P. & Corporate Treasurer | Form 4 sale | 2,065 | $316k | 30.7% | Unusual | SEC |
| Aug 8, 2019 | Rosebrough Walter M Jr | President & CEO | Form 4 sale | 102,500 | $15.6M | 62.8% | Unusual | SEC |
| Aug 7, 2019 | Majors Cary L | VP, N America Com Operations | Form 4 sale | 5,250 | $802k | 21.5% | Plan not stated | SEC |
| Aug 7, 2019 | Carestio Daniel A | Sr VP and Chief Operating Off | Form 4 sale | 7,000 | $1M | 22.6% | Plan not stated | SEC |
| Jun 28, 2019 | Bardwell Kathleen | Sr.V. P. & C.C.O. | Form 4 sale | 7,000 | $1M | 28.7% | Unusual | SEC |
| Jun 21, 2019 | Tokich Michael J | Sr. Vice Pres., CFO | Form 4 sale | 22,000 | $3.2M | 30.3% | Unusual | SEC |
| Jun 19, 2019 | Bardwell Kathleen | Sr.V. P. & C.C.O. | Form 4 sale | 5,360 | $777k | 23.5% | Plan not stated | SEC |
| Jun 7, 2019 | Steeves Richard Martin | Director | Form 4 sale | 221,493 | $30.5M | 100.0% | Unusual | SEC |
| Jun 6, 2019 | Steeves Richard Martin | Director | Form 4 sale | 72,867 | $10M | 68.5% | Unusual | SEC |
| Jun 5, 2019 | Steeves Richard Martin | Director | Form 4 sale | 213,197 | $28.9M | 66.7% | Unusual | SEC |
| Jun 4, 2019 | Wilson Loyal W | Director | Form 4 sale | 8,289 | $1.1M | 25.7% | Unusual | SEC |
| Jun 4, 2019 | Burton Karen L | VP, Controller & CAO | Form 4 sale | 7,500 | $1M | 49.0% | Unusual | SEC |
| Jun 3, 2019 | Burton Karen L | VP, Controller & CAO | Form 4 sale | 1,387 | $186k | 15.1% | Plan not stated | SEC |
| May 31, 2019 | Zangerle John Adam | Sr. VP, Gen Counsel, and Sec. | Form 4 sale | 1,500 | $198k | 4.5% | Plan not stated | SEC |
| May 31, 2019 | Rosebrough Walter M Jr | President & CEO | Form 4 sale | 119,000 | $15.8M | 73.0% | Unusual | SEC |
| May 21, 2019 | Sohi Mohsen | Director | Form 4 sale | 3,133 | $426k | 12.3% | Plan not stated | SEC |
| May 16, 2019 | Wood Michael B | Director | Form 4 sale | 5,700 | $768k | 25.5% | Unusual | SEC |
| May 15, 2019 | Kosecoff Jacqueline B | Director | Form 4 sale | 3,609 | $477k | 100.0% | Unusual | SEC |